← Leaderboards
Jacob Gardinier Scott
Cleveland Clinic Lerner Com-Cwru
$5,304,525
Attributed
$6,419,347
Total exposure
4
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.6M · FY2020–25$2M$1.5M$1M$500K$0
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$6,419,347 · 4
By mechanism
R37$3,455,434 · 1
U01$2,229,645 · 1
U54$734,268 · 2
Top collaborators
- Andriy Marusyk9 shared
Most similar at Cleveland Clinic Lerner Com-Cwru
Same institution · by research overlap
- Jae U Jung$74,270,295
- Feixiong Cheng$12,816,805
- Hisashi Tanaka$4,123,912
- Christine M O'Connor$5,218,324
- Leslie A Bruggeman$6,011,357
Others in their field
Other Emerging Leaders on “Malignant Neoplasms”
- Leonard Freedman · Leidos Biomedical Research, Inc.$527,106,485
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$357,875,933
- Lynn Briscoe · Leidos Biomedical Research, Inc.$186,892,879
- Leonard Freedmand · Leidos Biomedical Research, Inc.$108,968,336
- Beverly Hayes · Leidos Biomedical Research, Inc.$98,336,166
- Martha Hering · Westat, Inc.$57,098,843
Research focus
Malignant NeoplasmsTranslatingIn VivoResistanceTargeted TreatmentClinicTumorInsightEvolutionMutationMathematicsMathematical ModelPhenotypeAutomobile DrivingNon-Small-Cell Lung CarcinomaNeoplastic CellPressureComputer ModelsGame TheoryEpidermal Growth Factor ReceptorBiologyDesignClinically RelevantPharmaceutical Preparations
Grant awards (25)
Exploiting Ecology and Evolution to Prevent Therapy Resistance in EGFR-Driven Lung Cancer$497,509
R37 · FY2025 · CA · contact PI
Extending experimental evolutionary game theory in cancer in vivo to enable clinical translation: integrating spatio-temporal dynamics using mathematical modeling$363,660
U01 · FY2025 · CA · contact PI
Extending experimental evolutionary game theory in cancer in vivo to enable clinical translation: integrating spatio-temporal dynamics using mathematical modeling$185,401
U01 · FY2025 · CA · contact PI
Project 2: Transcriptional Dynamics and Temporal Reprogramming During Radiation Treatment$176,714
U54 · FY2025 · CA · contact PI
Extending experimental evolutionary game theory in cancer in vivo to enable clinical translation: integrating spatio-temporal dynamics using mathematical modeling$160,274
U01 · FY2025 · CA · contact PI
Extending experimental evolutionary game theory in cancer in vivo to enable clinical translation: integrating spatio-temporal dynamics using mathematical modeling$507,671
U01 · FY2024 · CA · contact PI
Exploiting Ecology and Evolution to Prevent Therapy Resistance in EGFR-Driven Lung Cancer$425,251
R37 · FY2024 · CA · contact PI
Extending experimental evolutionary game theory in cancer in vivo to enable clinical translation: integrating spatio-temporal dynamics using mathematical modeling$203,444
U01 · FY2024 · CA · contact PI
Extending experimental evolutionary game theory in cancer in vivo to enable clinical translation: integrating spatio-temporal dynamics using mathematical modeling$192,327
U01 · FY2024 · CA · contact PI
Project 2: Transcriptional Dynamics and Temporal Reprogramming During Radiation Treatment$183,964
U54 · FY2024 · CA · contact PI
Extending experimental evolutionary game theory in cancer in vivo to enable clinical translation: integrating spatio-temporal dynamics using mathematical modeling$33,742
U01 · FY2024 · CA · contact PI
Extending experimental evolutionary game theory in cancer in vivo to enable clinical translation: integrating spatio-temporal dynamics using mathematical modeling$25,129
U01 · FY2024 · CA · contact PI
Extending experimental evolutionary game theory in cancer in vivo to enable clinical translation: integrating spatio-temporal dynamics using mathematical modeling$557,997
U01 · FY2023 · CA · contact PI
Exploiting Ecology and Evolution to Prevent Therapy Resistance in EGFR-Driven Lung Cancer$438,678
R37 · FY2023 · CA · contact PI
Project 2: Transcriptional Dynamics and Temporal Reprogramming During Radiation Treatment$177,762
U54 · FY2023 · CA · contact PI
Exploiting Ecology and Evolution to Prevent Therapy Resistance in EGFR-Driven Lung Cancer$119,304
R37 · FY2023 · CA · contact PI
Exploiting Ecology and Evolution to Prevent Therapy Resistance in EGFR-Driven Lung Cancer$447,631
R37 · FY2022 · CA · contact PI
Exploiting Ecology and Evolution to Prevent Therapy Resistance in EGFR-Driven Lung Cancer$198,706
R37 · FY2022 · CA · contact PI
Project 2: Transcriptional Dynamics and Temporal Reprogramming During Radiation Treatment$195,828
U54 · FY2022 · CA · contact PI
Exploiting Ecology and Evolution to Prevent Therapy Resistance in EGFR-Driven Lung Cancer$56,654
R37 · FY2022 · CA · contact PI
Exploiting Ecology and Evolution to Prevent Therapy Resistance in EGFR-Driven Lung Cancer$629,824
R37 · FY2021 · CA · contact PI
Exploiting Ecology and Evolution to Prevent Therapy Resistance in EGFR-Driven Lung Cancer$76,968
R37 · FY2021 · CA · contact PI
Exploiting Ecology and Evolution to Prevent Therapy Resistance in EGFR-Driven Lung Cancer$468,495
R37 · FY2020 · CA · contact PI
Exploiting Ecology and Evolution to Prevent Therapy Resistance in EGFR-Driven Lung Cancer$74,312
R37 · FY2020 · CA · contact PI
Exploiting Ecology and Evolution to Prevent Therapy Resistance in EGFR-Driven Lung Cancer$22,102
R37 · FY2020 · CA · contact PI